nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—HRH2—coronary artery disease	0.204	0.488	CbGaD
Asenapine—HTR7—coronary artery disease	0.0695	0.166	CbGaD
Asenapine—ADRB1—coronary artery disease	0.0595	0.142	CbGaD
Asenapine—ADRB2—coronary artery disease	0.05	0.12	CbGaD
Asenapine—HTR1B—Penbutolol—coronary artery disease	0.0416	0.138	CbGbCtD
Asenapine—HTR2A—coronary artery disease	0.0349	0.0835	CbGaD
Asenapine—ADRB2—Penbutolol—coronary artery disease	0.0331	0.11	CbGbCtD
Asenapine—ADRB1—Penbutolol—coronary artery disease	0.0326	0.108	CbGbCtD
Asenapine—HTR1A—Penbutolol—coronary artery disease	0.0261	0.0867	CbGbCtD
Asenapine—ADRB2—Timolol—coronary artery disease	0.0233	0.0775	CbGbCtD
Asenapine—ADRB1—Timolol—coronary artery disease	0.0229	0.0763	CbGbCtD
Asenapine—CYP1A2—Gemfibrozil—coronary artery disease	0.0116	0.0386	CbGbCtD
Asenapine—CYP1A2—Clopidogrel—coronary artery disease	0.0101	0.0335	CbGbCtD
Asenapine—CYP3A4—Ticagrelor—coronary artery disease	0.00853	0.0284	CbGbCtD
Asenapine—CYP3A4—Fenofibrate—coronary artery disease	0.0076	0.0253	CbGbCtD
Asenapine—CYP2D6—Niacin—coronary artery disease	0.00628	0.0209	CbGbCtD
Asenapine—CYP3A4—Gemfibrozil—coronary artery disease	0.00608	0.0202	CbGbCtD
Asenapine—CYP2D6—Timolol—coronary artery disease	0.00584	0.0194	CbGbCtD
Asenapine—HTR2B—cardial valve—coronary artery disease	0.00548	0.152	CbGeAlD
Asenapine—CYP3A4—Clopidogrel—coronary artery disease	0.00527	0.0175	CbGbCtD
Asenapine—CYP2D6—Captopril—coronary artery disease	0.00514	0.0171	CbGbCtD
Asenapine—CYP2D6—Simvastatin—coronary artery disease	0.00497	0.0165	CbGbCtD
Asenapine—CYP1A2—Losartan—coronary artery disease	0.00491	0.0163	CbGbCtD
Asenapine—CYP3A4—Eplerenone—coronary artery disease	0.0049	0.0163	CbGbCtD
Asenapine—CYP2D6—Lovastatin—coronary artery disease	0.00486	0.0162	CbGbCtD
Asenapine—CYP2D6—Pravastatin—coronary artery disease	0.00486	0.0162	CbGbCtD
Asenapine—CYP2D6—Atorvastatin—coronary artery disease	0.00443	0.0147	CbGbCtD
Asenapine—CYP3A4—Enalapril—coronary artery disease	0.00437	0.0145	CbGbCtD
Asenapine—CYP3A4—Rosuvastatin—coronary artery disease	0.0034	0.0113	CbGbCtD
Asenapine—CYP3A4—Ezetimibe—coronary artery disease	0.0034	0.0113	CbGbCtD
Asenapine—CYP3A4—Simvastatin—coronary artery disease	0.00316	0.0105	CbGbCtD
Asenapine—CYP3A4—Pravastatin—coronary artery disease	0.00309	0.0103	CbGbCtD
Asenapine—CYP3A4—Lovastatin—coronary artery disease	0.00309	0.0103	CbGbCtD
Asenapine—CYP3A4—Atorvastatin—coronary artery disease	0.00281	0.00936	CbGbCtD
Asenapine—CYP3A4—Losartan—coronary artery disease	0.00257	0.00856	CbGbCtD
Asenapine—HTR7—pulmonary artery—coronary artery disease	0.0019	0.0528	CbGeAlD
Asenapine—HTR7—sympathetic nervous system—coronary artery disease	0.00185	0.0513	CbGeAlD
Asenapine—HTR2A—arteriole—coronary artery disease	0.00181	0.0502	CbGeAlD
Asenapine—HTR7—vagus nerve—coronary artery disease	0.00179	0.0497	CbGeAlD
Asenapine—HTR7—vein—coronary artery disease	0.00173	0.048	CbGeAlD
Asenapine—HTR7—autonomic nervous system—coronary artery disease	0.00124	0.0345	CbGeAlD
Asenapine—HTR2A—pulmonary artery—coronary artery disease	0.00118	0.0329	CbGeAlD
Asenapine—HTR2A—sympathetic nervous system—coronary artery disease	0.00115	0.032	CbGeAlD
Asenapine—HTR2A—vagus nerve—coronary artery disease	0.00111	0.031	CbGeAlD
Asenapine—HTR2A—vein—coronary artery disease	0.00108	0.03	CbGeAlD
Asenapine—HTR1B—artery—coronary artery disease	0.000912	0.0254	CbGeAlD
Asenapine—HTR1D—artery—coronary artery disease	0.000883	0.0246	CbGeAlD
Asenapine—DRD4—heart—coronary artery disease	0.000824	0.0229	CbGeAlD
Asenapine—HTR2A—autonomic nervous system—coronary artery disease	0.000774	0.0215	CbGeAlD
Asenapine—HTR7—artery—coronary artery disease	0.000704	0.0196	CbGeAlD
Asenapine—Loxapine—HRH2—coronary artery disease	0.000658	0.407	CrCbGaD
Asenapine—UGT1A4—blood—coronary artery disease	0.000607	0.0169	CbGeAlD
Asenapine—HTR7—endothelium—coronary artery disease	0.000594	0.0165	CbGeAlD
Asenapine—HRH2—heart—coronary artery disease	0.00051	0.0142	CbGeAlD
Asenapine—ADRB1—cardiac ventricle—coronary artery disease	0.000482	0.0134	CbGeAlD
Asenapine—HRH2—cardiovascular system—coronary artery disease	0.000481	0.0134	CbGeAlD
Asenapine—ADRB1—myocardium—coronary artery disease	0.000453	0.0126	CbGeAlD
Asenapine—HTR2A—artery—coronary artery disease	0.000439	0.0122	CbGeAlD
Asenapine—HRH2—cardiac atrium—coronary artery disease	0.000436	0.0121	CbGeAlD
Asenapine—HRH2—blood—coronary artery disease	0.00038	0.0106	CbGeAlD
Asenapine—HTR2A—endothelium—coronary artery disease	0.000371	0.0103	CbGeAlD
Asenapine—ADRA2C—cardiac ventricle—coronary artery disease	0.000363	0.0101	CbGeAlD
Asenapine—ADRA2C—myocardium—coronary artery disease	0.000341	0.00949	CbGeAlD
Asenapine—HTR1B—cardiovascular system—coronary artery disease	0.000317	0.00882	CbGeAlD
Asenapine—ADRB1—heart—coronary artery disease	0.000316	0.00879	CbGeAlD
Asenapine—HTR1D—cardiovascular system—coronary artery disease	0.000307	0.00854	CbGeAlD
Asenapine—HTR2B—heart—coronary artery disease	0.000303	0.00841	CbGeAlD
Asenapine—ADRB1—cardiovascular system—coronary artery disease	0.000298	0.00829	CbGeAlD
Asenapine—Amoxapine—HTR7—coronary artery disease	0.000287	0.177	CrCbGaD
Asenapine—HTR2B—cardiovascular system—coronary artery disease	0.000286	0.00794	CbGeAlD
Asenapine—ADRB1—cardiac atrium—coronary artery disease	0.00027	0.00752	CbGeAlD
Asenapine—HTR7—heart—coronary artery disease	0.000259	0.00721	CbGeAlD
Asenapine—HTR1A—cardiovascular system—coronary artery disease	0.000256	0.00711	CbGeAlD
Asenapine—ADRA1A—heart—coronary artery disease	0.00025	0.00695	CbGeAlD
Asenapine—HTR7—cardiovascular system—coronary artery disease	0.000245	0.0068	CbGeAlD
Asenapine—ADRA2C—heart—coronary artery disease	0.000238	0.00662	CbGeAlD
Asenapine—ADRA1A—cardiovascular system—coronary artery disease	0.000236	0.00656	CbGeAlD
Asenapine—SLC6A4—blood—coronary artery disease	0.000228	0.00634	CbGeAlD
Asenapine—HTR2B—blood—coronary artery disease	0.000226	0.00628	CbGeAlD
Asenapine—Loxapine—HTR7—coronary artery disease	0.000224	0.138	CrCbGaD
Asenapine—ADRA2C—cardiac atrium—coronary artery disease	0.000204	0.00566	CbGeAlD
Asenapine—HTR7—blood—coronary artery disease	0.000193	0.00538	CbGeAlD
Asenapine—Loxapine—ADRB1—coronary artery disease	0.000192	0.119	CrCbGaD
Asenapine—ADRA2A—heart—coronary artery disease	0.00019	0.00528	CbGeAlD
Asenapine—ADRA1A—blood—coronary artery disease	0.000187	0.00519	CbGeAlD
Asenapine—ADRA2C—blood—coronary artery disease	0.000178	0.00494	CbGeAlD
Asenapine—ADRA2A—cardiac atrium—coronary artery disease	0.000163	0.00452	CbGeAlD
Asenapine—HTR2A—heart—coronary artery disease	0.000162	0.00449	CbGeAlD
Asenapine—CYP1A2—blood—coronary artery disease	0.000154	0.00429	CbGeAlD
Asenapine—HTR2A—cardiovascular system—coronary artery disease	0.000152	0.00424	CbGeAlD
Asenapine—Amoxapine—HTR2A—coronary artery disease	0.000144	0.0891	CrCbGaD
Asenapine—ADRA2A—blood—coronary artery disease	0.000142	0.00394	CbGeAlD
Asenapine—HTR2A—blood—coronary artery disease	0.000121	0.00335	CbGeAlD
Asenapine—Loxapine—HTR2A—coronary artery disease	0.000113	0.0696	CrCbGaD
Asenapine—CYP3A4—blood—coronary artery disease	0.000112	0.0031	CbGeAlD
Asenapine—CYP2D6—blood—coronary artery disease	0.00011	0.00305	CbGeAlD
Asenapine—Thrombocytopenia—Losartan—coronary artery disease	7.21e-05	0.000569	CcSEcCtD
Asenapine—Constipation—Enalapril—coronary artery disease	7.21e-05	0.000569	CcSEcCtD
Asenapine—Dyspnoea—Captopril—coronary artery disease	7.21e-05	0.000569	CcSEcCtD
Asenapine—Somnolence—Captopril—coronary artery disease	7.19e-05	0.000568	CcSEcCtD
Asenapine—Tachycardia—Losartan—coronary artery disease	7.18e-05	0.000568	CcSEcCtD
Asenapine—Gastrointestinal disorder—Telmisartan—coronary artery disease	7.18e-05	0.000567	CcSEcCtD
Asenapine—Fatigue—Telmisartan—coronary artery disease	7.17e-05	0.000566	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Perindopril—coronary artery disease	7.15e-05	0.000565	CcSEcCtD
Asenapine—Hypotension—Furosemide—coronary artery disease	7.13e-05	0.000563	CcSEcCtD
Asenapine—Dyspepsia—Captopril—coronary artery disease	7.12e-05	0.000562	CcSEcCtD
Asenapine—Constipation—Telmisartan—coronary artery disease	7.11e-05	0.000562	CcSEcCtD
Asenapine—Agitation—Ramipril—coronary artery disease	7.11e-05	0.000561	CcSEcCtD
Asenapine—Hypersensitivity—Simvastatin—coronary artery disease	7.1e-05	0.000561	CcSEcCtD
Asenapine—Insomnia—Perindopril—coronary artery disease	7.1e-05	0.000561	CcSEcCtD
Asenapine—Asthenia—Eplerenone—coronary artery disease	7.1e-05	0.000561	CcSEcCtD
Asenapine—Angioedema—Ramipril—coronary artery disease	7.07e-05	0.000558	CcSEcCtD
Asenapine—Mental disorder—Lisinopril—coronary artery disease	7.06e-05	0.000558	CcSEcCtD
Asenapine—Nausea—Acetylsalicylic acid—coronary artery disease	7.02e-05	0.000554	CcSEcCtD
Asenapine—Malnutrition—Lisinopril—coronary artery disease	7.01e-05	0.000554	CcSEcCtD
Asenapine—Dyspnoea—Perindopril—coronary artery disease	7e-05	0.000553	CcSEcCtD
Asenapine—Dizziness—Fenofibrate—coronary artery disease	6.98e-05	0.000551	CcSEcCtD
Asenapine—Somnolence—Perindopril—coronary artery disease	6.98e-05	0.000551	CcSEcCtD
Asenapine—Malaise—Ramipril—coronary artery disease	6.97e-05	0.000551	CcSEcCtD
Asenapine—Fatigue—Captopril—coronary artery disease	6.97e-05	0.000551	CcSEcCtD
Asenapine—Syncope—Ramipril—coronary artery disease	6.94e-05	0.000548	CcSEcCtD
Asenapine—Leukopenia—Ramipril—coronary artery disease	6.92e-05	0.000547	CcSEcCtD
Asenapine—Asthenia—Simvastatin—coronary artery disease	6.92e-05	0.000546	CcSEcCtD
Asenapine—Constipation—Captopril—coronary artery disease	6.91e-05	0.000546	CcSEcCtD
Asenapine—Angioedema—Timolol—coronary artery disease	6.91e-05	0.000546	CcSEcCtD
Asenapine—Dyspepsia—Perindopril—coronary artery disease	6.91e-05	0.000546	CcSEcCtD
Asenapine—Hypotension—Losartan—coronary artery disease	6.88e-05	0.000543	CcSEcCtD
Asenapine—Dysgeusia—Lisinopril—coronary artery disease	6.87e-05	0.000543	CcSEcCtD
Asenapine—Dizziness—Clopidogrel—coronary artery disease	6.86e-05	0.000542	CcSEcCtD
Asenapine—Dizziness—Lovastatin—coronary artery disease	6.81e-05	0.000538	CcSEcCtD
Asenapine—Loss of consciousness—Ramipril—coronary artery disease	6.8e-05	0.000537	CcSEcCtD
Asenapine—Somnolence—Furosemide—coronary artery disease	6.78e-05	0.000536	CcSEcCtD
Asenapine—Syncope—Timolol—coronary artery disease	6.78e-05	0.000536	CcSEcCtD
Asenapine—Gastrointestinal disorder—Perindopril—coronary artery disease	6.78e-05	0.000535	CcSEcCtD
Asenapine—Fatigue—Perindopril—coronary artery disease	6.77e-05	0.000535	CcSEcCtD
Asenapine—Muscle spasms—Lisinopril—coronary artery disease	6.74e-05	0.000533	CcSEcCtD
Asenapine—Constipation—Perindopril—coronary artery disease	6.71e-05	0.00053	CcSEcCtD
Asenapine—Vomiting—Fenofibrate—coronary artery disease	6.71e-05	0.00053	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Losartan—coronary artery disease	6.71e-05	0.00053	CcSEcCtD
Asenapine—Hypersensitivity—Valsartan—coronary artery disease	6.71e-05	0.00053	CcSEcCtD
Asenapine—Convulsion—Ramipril—coronary artery disease	6.7e-05	0.000529	CcSEcCtD
Asenapine—Dizziness—Ezetimibe—coronary artery disease	6.68e-05	0.000528	CcSEcCtD
Asenapine—Insomnia—Losartan—coronary artery disease	6.66e-05	0.000526	CcSEcCtD
Asenapine—Rash—Fenofibrate—coronary artery disease	6.65e-05	0.000526	CcSEcCtD
Asenapine—Dermatitis—Fenofibrate—coronary artery disease	6.65e-05	0.000525	CcSEcCtD
Asenapine—Loss of consciousness—Timolol—coronary artery disease	6.65e-05	0.000525	CcSEcCtD
Asenapine—Headache—Fenofibrate—coronary artery disease	6.61e-05	0.000522	CcSEcCtD
Asenapine—Vomiting—Clopidogrel—coronary artery disease	6.6e-05	0.000521	CcSEcCtD
Asenapine—Gastrointestinal disorder—Furosemide—coronary artery disease	6.59e-05	0.00052	CcSEcCtD
Asenapine—Arthralgia—Ramipril—coronary artery disease	6.58e-05	0.00052	CcSEcCtD
Asenapine—Fatigue—Furosemide—coronary artery disease	6.58e-05	0.00052	CcSEcCtD
Asenapine—Tremor—Lisinopril—coronary artery disease	6.57e-05	0.000519	CcSEcCtD
Asenapine—Dyspnoea—Losartan—coronary artery disease	6.56e-05	0.000518	CcSEcCtD
Asenapine—Anxiety—Ramipril—coronary artery disease	6.56e-05	0.000518	CcSEcCtD
Asenapine—Vomiting—Lovastatin—coronary artery disease	6.55e-05	0.000518	CcSEcCtD
Asenapine—Somnolence—Losartan—coronary artery disease	6.54e-05	0.000517	CcSEcCtD
Asenapine—Dizziness—Eplerenone—coronary artery disease	6.54e-05	0.000517	CcSEcCtD
Asenapine—Rash—Clopidogrel—coronary artery disease	6.54e-05	0.000517	CcSEcCtD
Asenapine—Dermatitis—Clopidogrel—coronary artery disease	6.53e-05	0.000516	CcSEcCtD
Asenapine—Asthenia—Valsartan—coronary artery disease	6.53e-05	0.000516	CcSEcCtD
Asenapine—Hypertension—Timolol—coronary artery disease	6.53e-05	0.000516	CcSEcCtD
Asenapine—Constipation—Furosemide—coronary artery disease	6.52e-05	0.000515	CcSEcCtD
Asenapine—Hypersensitivity—Niacin—coronary artery disease	6.52e-05	0.000515	CcSEcCtD
Asenapine—Asthenia—Olmesartan—coronary artery disease	6.5e-05	0.000513	CcSEcCtD
Asenapine—Headache—Clopidogrel—coronary artery disease	6.5e-05	0.000513	CcSEcCtD
Asenapine—Rash—Lovastatin—coronary artery disease	6.5e-05	0.000513	CcSEcCtD
Asenapine—Dermatitis—Lovastatin—coronary artery disease	6.49e-05	0.000513	CcSEcCtD
Asenapine—Anaemia—Lisinopril—coronary artery disease	6.48e-05	0.000512	CcSEcCtD
Asenapine—Dyspepsia—Losartan—coronary artery disease	6.48e-05	0.000512	CcSEcCtD
Asenapine—Headache—Lovastatin—coronary artery disease	6.46e-05	0.00051	CcSEcCtD
Asenapine—Dry mouth—Ramipril—coronary artery disease	6.44e-05	0.000509	CcSEcCtD
Asenapine—Arthralgia—Timolol—coronary artery disease	6.44e-05	0.000509	CcSEcCtD
Asenapine—Vomiting—Ezetimibe—coronary artery disease	6.43e-05	0.000508	CcSEcCtD
Asenapine—Hypersensitivity—Pravastatin—coronary artery disease	6.42e-05	0.000507	CcSEcCtD
Asenapine—Anxiety—Timolol—coronary artery disease	6.42e-05	0.000507	CcSEcCtD
Asenapine—Angioedema—Lisinopril—coronary artery disease	6.41e-05	0.000506	CcSEcCtD
Asenapine—Dizziness—Simvastatin—coronary artery disease	6.37e-05	0.000503	CcSEcCtD
Asenapine—Rash—Ezetimibe—coronary artery disease	6.37e-05	0.000503	CcSEcCtD
Asenapine—Dermatitis—Ezetimibe—coronary artery disease	6.37e-05	0.000503	CcSEcCtD
Asenapine—Asthenia—Niacin—coronary artery disease	6.35e-05	0.000502	CcSEcCtD
Asenapine—Fatigue—Losartan—coronary artery disease	6.35e-05	0.000501	CcSEcCtD
Asenapine—Headache—Ezetimibe—coronary artery disease	6.33e-05	0.0005	CcSEcCtD
Asenapine—Malaise—Lisinopril—coronary artery disease	6.33e-05	0.0005	CcSEcCtD
Asenapine—Anaphylactic shock—Ramipril—coronary artery disease	6.31e-05	0.000499	CcSEcCtD
Asenapine—Dry mouth—Timolol—coronary artery disease	6.3e-05	0.000497	CcSEcCtD
Asenapine—Constipation—Losartan—coronary artery disease	6.3e-05	0.000497	CcSEcCtD
Asenapine—Syncope—Lisinopril—coronary artery disease	6.29e-05	0.000497	CcSEcCtD
Asenapine—Vomiting—Eplerenone—coronary artery disease	6.29e-05	0.000497	CcSEcCtD
Asenapine—Leukopenia—Lisinopril—coronary artery disease	6.28e-05	0.000496	CcSEcCtD
Asenapine—Nausea—Fenofibrate—coronary artery disease	6.27e-05	0.000495	CcSEcCtD
Asenapine—Asthenia—Pravastatin—coronary artery disease	6.25e-05	0.000494	CcSEcCtD
Asenapine—Rash—Eplerenone—coronary artery disease	6.24e-05	0.000493	CcSEcCtD
Asenapine—Hypersensitivity—Trandolapril—coronary artery disease	6.23e-05	0.000492	CcSEcCtD
Asenapine—Dermatitis—Eplerenone—coronary artery disease	6.23e-05	0.000492	CcSEcCtD
Asenapine—Shock—Ramipril—coronary artery disease	6.21e-05	0.000491	CcSEcCtD
Asenapine—Hypersensitivity—Enalapril—coronary artery disease	6.21e-05	0.000491	CcSEcCtD
Asenapine—Headache—Eplerenone—coronary artery disease	6.2e-05	0.00049	CcSEcCtD
Asenapine—Nervous system disorder—Ramipril—coronary artery disease	6.19e-05	0.000489	CcSEcCtD
Asenapine—Thrombocytopenia—Ramipril—coronary artery disease	6.18e-05	0.000488	CcSEcCtD
Asenapine—Anaphylactic shock—Timolol—coronary artery disease	6.17e-05	0.000487	CcSEcCtD
Asenapine—Loss of consciousness—Lisinopril—coronary artery disease	6.17e-05	0.000487	CcSEcCtD
Asenapine—Nausea—Clopidogrel—coronary artery disease	6.16e-05	0.000487	CcSEcCtD
Asenapine—Tachycardia—Ramipril—coronary artery disease	6.16e-05	0.000487	CcSEcCtD
Asenapine—Vomiting—Simvastatin—coronary artery disease	6.13e-05	0.000484	CcSEcCtD
Asenapine—Hypersensitivity—Telmisartan—coronary artery disease	6.12e-05	0.000484	CcSEcCtD
Asenapine—Nausea—Lovastatin—coronary artery disease	6.12e-05	0.000484	CcSEcCtD
Asenapine—Rash—Simvastatin—coronary artery disease	6.08e-05	0.00048	CcSEcCtD
Asenapine—Dermatitis—Simvastatin—coronary artery disease	6.07e-05	0.00048	CcSEcCtD
Asenapine—Asthenia—Trandolapril—coronary artery disease	6.07e-05	0.00048	CcSEcCtD
Asenapine—Shock—Timolol—coronary artery disease	6.07e-05	0.00048	CcSEcCtD
Asenapine—Nervous system disorder—Timolol—coronary artery disease	6.05e-05	0.000478	CcSEcCtD
Asenapine—Asthenia—Enalapril—coronary artery disease	6.05e-05	0.000478	CcSEcCtD
Asenapine—Headache—Simvastatin—coronary artery disease	6.04e-05	0.000477	CcSEcCtD
Asenapine—Dizziness—Valsartan—coronary artery disease	6.02e-05	0.000475	CcSEcCtD
Asenapine—Nausea—Ezetimibe—coronary artery disease	6e-05	0.000474	CcSEcCtD
Asenapine—Dizziness—Olmesartan—coronary artery disease	5.99e-05	0.000473	CcSEcCtD
Asenapine—Arthralgia—Lisinopril—coronary artery disease	5.97e-05	0.000472	CcSEcCtD
Asenapine—Asthenia—Telmisartan—coronary artery disease	5.96e-05	0.000471	CcSEcCtD
Asenapine—Anxiety—Lisinopril—coronary artery disease	5.95e-05	0.00047	CcSEcCtD
Asenapine—Hypotension—Ramipril—coronary artery disease	5.9e-05	0.000466	CcSEcCtD
Asenapine—Nausea—Eplerenone—coronary artery disease	5.88e-05	0.000464	CcSEcCtD
Asenapine—Dizziness—Niacin—coronary artery disease	5.85e-05	0.000462	CcSEcCtD
Asenapine—Dry mouth—Lisinopril—coronary artery disease	5.84e-05	0.000461	CcSEcCtD
Asenapine—Asthenia—Captopril—coronary artery disease	5.8e-05	0.000458	CcSEcCtD
Asenapine—Vomiting—Valsartan—coronary artery disease	5.79e-05	0.000457	CcSEcCtD
Asenapine—Hypotension—Timolol—coronary artery disease	5.77e-05	0.000456	CcSEcCtD
Asenapine—Dizziness—Pravastatin—coronary artery disease	5.76e-05	0.000455	CcSEcCtD
Asenapine—Vomiting—Olmesartan—coronary artery disease	5.76e-05	0.000455	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Ramipril—coronary artery disease	5.75e-05	0.000454	CcSEcCtD
Asenapine—Rash—Valsartan—coronary artery disease	5.74e-05	0.000453	CcSEcCtD
Asenapine—Dermatitis—Valsartan—coronary artery disease	5.73e-05	0.000453	CcSEcCtD
Asenapine—Nausea—Simvastatin—coronary artery disease	5.73e-05	0.000452	CcSEcCtD
Asenapine—Anaphylactic shock—Lisinopril—coronary artery disease	5.72e-05	0.000452	CcSEcCtD
Asenapine—Rash—Olmesartan—coronary artery disease	5.71e-05	0.000451	CcSEcCtD
Asenapine—Insomnia—Ramipril—coronary artery disease	5.71e-05	0.000451	CcSEcCtD
Asenapine—Dermatitis—Olmesartan—coronary artery disease	5.71e-05	0.000451	CcSEcCtD
Asenapine—Headache—Valsartan—coronary artery disease	5.7e-05	0.00045	CcSEcCtD
Asenapine—Headache—Olmesartan—coronary artery disease	5.67e-05	0.000448	CcSEcCtD
Asenapine—Shock—Lisinopril—coronary artery disease	5.63e-05	0.000445	CcSEcCtD
Asenapine—Asthenia—Perindopril—coronary artery disease	5.63e-05	0.000445	CcSEcCtD
Asenapine—Dyspnoea—Ramipril—coronary artery disease	5.63e-05	0.000445	CcSEcCtD
Asenapine—Vomiting—Niacin—coronary artery disease	5.63e-05	0.000445	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Timolol—coronary artery disease	5.62e-05	0.000444	CcSEcCtD
Asenapine—Hypersensitivity—Furosemide—coronary artery disease	5.62e-05	0.000444	CcSEcCtD
Asenapine—Somnolence—Ramipril—coronary artery disease	5.61e-05	0.000443	CcSEcCtD
Asenapine—Thrombocytopenia—Lisinopril—coronary artery disease	5.61e-05	0.000443	CcSEcCtD
Asenapine—Dizziness—Trandolapril—coronary artery disease	5.6e-05	0.000442	CcSEcCtD
Asenapine—Tachycardia—Lisinopril—coronary artery disease	5.59e-05	0.000441	CcSEcCtD
Asenapine—Insomnia—Timolol—coronary artery disease	5.58e-05	0.000441	CcSEcCtD
Asenapine—Rash—Niacin—coronary artery disease	5.58e-05	0.000441	CcSEcCtD
Asenapine—Dermatitis—Niacin—coronary artery disease	5.58e-05	0.00044	CcSEcCtD
Asenapine—Dizziness—Enalapril—coronary artery disease	5.57e-05	0.00044	CcSEcCtD
Asenapine—Dyspepsia—Ramipril—coronary artery disease	5.56e-05	0.000439	CcSEcCtD
Asenapine—Headache—Niacin—coronary artery disease	5.54e-05	0.000438	CcSEcCtD
Asenapine—Vomiting—Pravastatin—coronary artery disease	5.54e-05	0.000438	CcSEcCtD
Asenapine—Dyspnoea—Timolol—coronary artery disease	5.5e-05	0.000435	CcSEcCtD
Asenapine—Dizziness—Telmisartan—coronary artery disease	5.5e-05	0.000434	CcSEcCtD
Asenapine—Rash—Pravastatin—coronary artery disease	5.49e-05	0.000434	CcSEcCtD
Asenapine—Dermatitis—Pravastatin—coronary artery disease	5.49e-05	0.000434	CcSEcCtD
Asenapine—Somnolence—Timolol—coronary artery disease	5.49e-05	0.000433	CcSEcCtD
Asenapine—Asthenia—Furosemide—coronary artery disease	5.47e-05	0.000432	CcSEcCtD
Asenapine—Headache—Pravastatin—coronary artery disease	5.46e-05	0.000431	CcSEcCtD
Asenapine—Gastrointestinal disorder—Ramipril—coronary artery disease	5.45e-05	0.00043	CcSEcCtD
Asenapine—Fatigue—Ramipril—coronary artery disease	5.44e-05	0.00043	CcSEcCtD
Asenapine—Dyspepsia—Timolol—coronary artery disease	5.43e-05	0.000429	CcSEcCtD
Asenapine—Hypersensitivity—Losartan—coronary artery disease	5.42e-05	0.000428	CcSEcCtD
Asenapine—Nausea—Valsartan—coronary artery disease	5.41e-05	0.000427	CcSEcCtD
Asenapine—Constipation—Ramipril—coronary artery disease	5.4e-05	0.000426	CcSEcCtD
Asenapine—Nausea—Olmesartan—coronary artery disease	5.38e-05	0.000425	CcSEcCtD
Asenapine—Vomiting—Trandolapril—coronary artery disease	5.38e-05	0.000425	CcSEcCtD
Asenapine—Vomiting—Enalapril—coronary artery disease	5.36e-05	0.000423	CcSEcCtD
Asenapine—Hypotension—Lisinopril—coronary artery disease	5.35e-05	0.000423	CcSEcCtD
Asenapine—Dizziness—Captopril—coronary artery disease	5.35e-05	0.000422	CcSEcCtD
Asenapine—Rash—Trandolapril—coronary artery disease	5.34e-05	0.000421	CcSEcCtD
Asenapine—Dermatitis—Trandolapril—coronary artery disease	5.33e-05	0.000421	CcSEcCtD
Asenapine—Gastrointestinal disorder—Timolol—coronary artery disease	5.33e-05	0.000421	CcSEcCtD
Asenapine—Fatigue—Timolol—coronary artery disease	5.32e-05	0.00042	CcSEcCtD
Asenapine—Rash—Enalapril—coronary artery disease	5.31e-05	0.00042	CcSEcCtD
Asenapine—Dermatitis—Enalapril—coronary artery disease	5.31e-05	0.000419	CcSEcCtD
Asenapine—Headache—Trandolapril—coronary artery disease	5.3e-05	0.000419	CcSEcCtD
Asenapine—Vomiting—Telmisartan—coronary artery disease	5.29e-05	0.000418	CcSEcCtD
Asenapine—Asthenia—Losartan—coronary artery disease	5.28e-05	0.000417	CcSEcCtD
Asenapine—Headache—Enalapril—coronary artery disease	5.28e-05	0.000417	CcSEcCtD
Asenapine—Nausea—Niacin—coronary artery disease	5.26e-05	0.000415	CcSEcCtD
Asenapine—Rash—Telmisartan—coronary artery disease	5.24e-05	0.000414	CcSEcCtD
Asenapine—Dermatitis—Telmisartan—coronary artery disease	5.24e-05	0.000414	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	5.22e-05	0.000412	CcSEcCtD
Asenapine—Headache—Telmisartan—coronary artery disease	5.21e-05	0.000411	CcSEcCtD
Asenapine—Dizziness—Perindopril—coronary artery disease	5.19e-05	0.00041	CcSEcCtD
Asenapine—Insomnia—Lisinopril—coronary artery disease	5.18e-05	0.000409	CcSEcCtD
Asenapine—Nausea—Pravastatin—coronary artery disease	5.18e-05	0.000409	CcSEcCtD
Asenapine—Vomiting—Captopril—coronary artery disease	5.14e-05	0.000406	CcSEcCtD
Asenapine—Dyspnoea—Lisinopril—coronary artery disease	5.1e-05	0.000403	CcSEcCtD
Asenapine—Rash—Captopril—coronary artery disease	5.1e-05	0.000403	CcSEcCtD
Asenapine—Dermatitis—Captopril—coronary artery disease	5.09e-05	0.000402	CcSEcCtD
Asenapine—Somnolence—Lisinopril—coronary artery disease	5.09e-05	0.000402	CcSEcCtD
Asenapine—Headache—Captopril—coronary artery disease	5.06e-05	0.0004	CcSEcCtD
Asenapine—Dizziness—Furosemide—coronary artery disease	5.05e-05	0.000399	CcSEcCtD
Asenapine—Dyspepsia—Lisinopril—coronary artery disease	5.04e-05	0.000398	CcSEcCtD
Asenapine—Nausea—Trandolapril—coronary artery disease	5.03e-05	0.000397	CcSEcCtD
Asenapine—Nausea—Enalapril—coronary artery disease	5.01e-05	0.000395	CcSEcCtD
Asenapine—Vomiting—Perindopril—coronary artery disease	4.99e-05	0.000394	CcSEcCtD
Asenapine—Rash—Perindopril—coronary artery disease	4.95e-05	0.000391	CcSEcCtD
Asenapine—Dermatitis—Perindopril—coronary artery disease	4.94e-05	0.000391	CcSEcCtD
Asenapine—Gastrointestinal disorder—Lisinopril—coronary artery disease	4.94e-05	0.00039	CcSEcCtD
Asenapine—Nausea—Telmisartan—coronary artery disease	4.94e-05	0.00039	CcSEcCtD
Asenapine—Fatigue—Lisinopril—coronary artery disease	4.94e-05	0.00039	CcSEcCtD
Asenapine—Headache—Perindopril—coronary artery disease	4.92e-05	0.000388	CcSEcCtD
Asenapine—Constipation—Lisinopril—coronary artery disease	4.9e-05	0.000387	CcSEcCtD
Asenapine—Dizziness—Losartan—coronary artery disease	4.87e-05	0.000385	CcSEcCtD
Asenapine—Vomiting—Furosemide—coronary artery disease	4.85e-05	0.000383	CcSEcCtD
Asenapine—Rash—Furosemide—coronary artery disease	4.81e-05	0.00038	CcSEcCtD
Asenapine—Dermatitis—Furosemide—coronary artery disease	4.81e-05	0.00038	CcSEcCtD
Asenapine—Nausea—Captopril—coronary artery disease	4.8e-05	0.000379	CcSEcCtD
Asenapine—Headache—Furosemide—coronary artery disease	4.78e-05	0.000378	CcSEcCtD
Asenapine—Vomiting—Losartan—coronary artery disease	4.68e-05	0.00037	CcSEcCtD
Asenapine—Nausea—Perindopril—coronary artery disease	4.66e-05	0.000368	CcSEcCtD
Asenapine—Hypersensitivity—Ramipril—coronary artery disease	4.65e-05	0.000367	CcSEcCtD
Asenapine—Rash—Losartan—coronary artery disease	4.64e-05	0.000367	CcSEcCtD
Asenapine—Dermatitis—Losartan—coronary artery disease	4.64e-05	0.000366	CcSEcCtD
Asenapine—Headache—Losartan—coronary artery disease	4.61e-05	0.000364	CcSEcCtD
Asenapine—Hypersensitivity—Timolol—coronary artery disease	4.55e-05	0.000359	CcSEcCtD
Asenapine—Nausea—Furosemide—coronary artery disease	4.53e-05	0.000358	CcSEcCtD
Asenapine—Asthenia—Ramipril—coronary artery disease	4.53e-05	0.000358	CcSEcCtD
Asenapine—Asthenia—Timolol—coronary artery disease	4.43e-05	0.00035	CcSEcCtD
Asenapine—Nausea—Losartan—coronary artery disease	4.37e-05	0.000345	CcSEcCtD
Asenapine—Hypersensitivity—Lisinopril—coronary artery disease	4.22e-05	0.000333	CcSEcCtD
Asenapine—Dizziness—Ramipril—coronary artery disease	4.17e-05	0.00033	CcSEcCtD
Asenapine—Asthenia—Lisinopril—coronary artery disease	4.11e-05	0.000324	CcSEcCtD
Asenapine—Dizziness—Timolol—coronary artery disease	4.08e-05	0.000322	CcSEcCtD
Asenapine—Vomiting—Ramipril—coronary artery disease	4.01e-05	0.000317	CcSEcCtD
Asenapine—Rash—Ramipril—coronary artery disease	3.98e-05	0.000314	CcSEcCtD
Asenapine—Dermatitis—Ramipril—coronary artery disease	3.98e-05	0.000314	CcSEcCtD
Asenapine—Headache—Ramipril—coronary artery disease	3.95e-05	0.000312	CcSEcCtD
Asenapine—Vomiting—Timolol—coronary artery disease	3.92e-05	0.00031	CcSEcCtD
Asenapine—Rash—Timolol—coronary artery disease	3.89e-05	0.000307	CcSEcCtD
Asenapine—Dermatitis—Timolol—coronary artery disease	3.89e-05	0.000307	CcSEcCtD
Asenapine—Headache—Timolol—coronary artery disease	3.87e-05	0.000305	CcSEcCtD
Asenapine—Dizziness—Lisinopril—coronary artery disease	3.79e-05	0.000299	CcSEcCtD
Asenapine—Nausea—Ramipril—coronary artery disease	3.75e-05	0.000296	CcSEcCtD
Asenapine—Nausea—Timolol—coronary artery disease	3.67e-05	0.00029	CcSEcCtD
Asenapine—Vomiting—Lisinopril—coronary artery disease	3.64e-05	0.000288	CcSEcCtD
Asenapine—Rash—Lisinopril—coronary artery disease	3.61e-05	0.000285	CcSEcCtD
Asenapine—Dermatitis—Lisinopril—coronary artery disease	3.61e-05	0.000285	CcSEcCtD
Asenapine—Headache—Lisinopril—coronary artery disease	3.59e-05	0.000283	CcSEcCtD
Asenapine—Nausea—Lisinopril—coronary artery disease	3.4e-05	0.000269	CcSEcCtD
Asenapine—HTR7—Signaling Pathways—MAPK1—coronary artery disease	8.14e-07	6.95e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—FGF2—coronary artery disease	8.13e-07	6.94e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—IL6—coronary artery disease	8.12e-07	6.94e-06	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—MAPK1—coronary artery disease	8.08e-07	6.9e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CASP3—coronary artery disease	8.07e-07	6.9e-06	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TGFB1—coronary artery disease	8.07e-07	6.89e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	8.06e-07	6.88e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—APOB—coronary artery disease	8.05e-07	6.87e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—CCND1—coronary artery disease	8.03e-07	6.86e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—NOS3—coronary artery disease	8.03e-07	6.86e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	8.02e-07	6.85e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—IL6—coronary artery disease	8.02e-07	6.85e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—NOS3—coronary artery disease	8.01e-07	6.85e-06	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—PTGS2—coronary artery disease	7.99e-07	6.83e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CXCL8—coronary artery disease	7.98e-07	6.82e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—FGF2—coronary artery disease	7.97e-07	6.81e-06	CbGpPWpGaD
Asenapine—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	7.97e-07	6.81e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CCND1—coronary artery disease	7.96e-07	6.8e-06	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TGFB1—coronary artery disease	7.94e-07	6.78e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—JAK2—coronary artery disease	7.93e-07	6.78e-06	CbGpPWpGaD
Asenapine—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	7.93e-07	6.77e-06	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—MAPK1—coronary artery disease	7.91e-07	6.76e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CASP3—coronary artery disease	7.89e-07	6.74e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—NOS3—coronary artery disease	7.86e-07	6.72e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CCND1—coronary artery disease	7.86e-07	6.71e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CASP3—coronary artery disease	7.85e-07	6.71e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—IL6—coronary artery disease	7.84e-07	6.7e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GSTM1—coronary artery disease	7.83e-07	6.69e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—JAK2—coronary artery disease	7.81e-07	6.67e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—IL6—coronary artery disease	7.8e-07	6.66e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MMP9—coronary artery disease	7.8e-07	6.66e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PLCB1—coronary artery disease	7.79e-07	6.66e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—JAK2—coronary artery disease	7.79e-07	6.65e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—VEGFA—coronary artery disease	7.79e-07	6.65e-06	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—MAPK1—coronary artery disease	7.79e-07	6.65e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	7.78e-07	6.64e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—AGT—coronary artery disease	7.76e-07	6.63e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MMP9—coronary artery disease	7.73e-07	6.6e-06	CbGpPWpGaD
Asenapine—ADRA2C—GPCR downstream signaling—AKT1—coronary artery disease	7.71e-07	6.59e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—VEGFA—coronary artery disease	7.69e-07	6.57e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CCND1—coronary artery disease	7.68e-07	6.56e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—LPL—coronary artery disease	7.68e-07	6.56e-06	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	7.66e-07	6.55e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	7.65e-07	6.54e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	7.65e-07	6.54e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—JAK2—coronary artery disease	7.64e-07	6.53e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CCND1—coronary artery disease	7.64e-07	6.53e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CASP3—coronary artery disease	7.64e-07	6.52e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	7.63e-07	6.52e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MMP9—coronary artery disease	7.63e-07	6.52e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—APOE—coronary artery disease	7.6e-07	6.49e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—IL6—coronary artery disease	7.59e-07	6.48e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TGFB1—coronary artery disease	7.58e-07	6.48e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	7.56e-07	6.46e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ABCA1—coronary artery disease	7.56e-07	6.45e-06	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—AKT1—coronary artery disease	7.53e-07	6.43e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—APOA1—coronary artery disease	7.51e-07	6.42e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GPX1—coronary artery disease	7.49e-07	6.4e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	7.49e-07	6.4e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	7.49e-07	6.4e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MMP9—coronary artery disease	7.46e-07	6.37e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	7.43e-07	6.35e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—MAPK1—coronary artery disease	7.43e-07	6.35e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MMP9—coronary artery disease	7.42e-07	6.34e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	7.41e-07	6.33e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	7.4e-07	6.32e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GOT1—coronary artery disease	7.32e-07	6.25e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GGT1—coronary artery disease	7.32e-07	6.25e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	7.31e-07	6.24e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CD36—coronary artery disease	7.3e-07	6.23e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CXCL8—coronary artery disease	7.24e-07	6.19e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	7.23e-07	6.18e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	7.22e-07	6.17e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	7.21e-07	6.16e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	7.2e-07	6.15e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TGFB1—coronary artery disease	7.15e-07	6.11e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	7.12e-07	6.09e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	7.11e-07	6.07e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	7.1e-07	6.07e-06	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—PIK3CA—coronary artery disease	7.07e-07	6.04e-06	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—PIK3CA—coronary artery disease	7.06e-07	6.03e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TGFB1—coronary artery disease	7.05e-07	6.03e-06	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—PIK3CA—coronary artery disease	7.01e-07	5.99e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—MAPK1—coronary artery disease	7.01e-07	5.99e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	7e-07	5.98e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	7e-07	5.98e-06	CbGpPWpGaD
Asenapine—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	6.99e-07	5.98e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	6.98e-07	5.96e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	6.96e-07	5.95e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	6.94e-07	5.93e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CASP3—coronary artery disease	6.93e-07	5.92e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—MAPK1—coronary artery disease	6.92e-07	5.91e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—MTHFR—coronary artery disease	6.92e-07	5.91e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—IL6—coronary artery disease	6.89e-07	5.88e-06	CbGpPWpGaD
Asenapine—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	6.88e-07	5.88e-06	CbGpPWpGaD
Asenapine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	6.87e-07	5.87e-06	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—PIK3CA—coronary artery disease	6.87e-07	5.87e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	6.85e-07	5.85e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CASP3—coronary artery disease	6.82e-07	5.82e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CASP3—coronary artery disease	6.8e-07	5.81e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—IL6—coronary artery disease	6.77e-07	5.79e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—IL6—coronary artery disease	6.76e-07	5.77e-06	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—PIK3CA—coronary artery disease	6.76e-07	5.77e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CCND1—coronary artery disease	6.75e-07	5.76e-06	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	6.74e-07	5.76e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	6.7e-07	5.72e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	6.68e-07	5.7e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	6.66e-07	5.69e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CCND1—coronary artery disease	6.64e-07	5.67e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	6.63e-07	5.67e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CCND1—coronary artery disease	6.62e-07	5.66e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PPARG—coronary artery disease	6.62e-07	5.66e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GSTP1—coronary artery disease	6.57e-07	5.61e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—AGT—coronary artery disease	6.57e-07	5.61e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MMP9—coronary artery disease	6.55e-07	5.59e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—POMC—coronary artery disease	6.53e-07	5.58e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	6.51e-07	5.56e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	6.5e-07	5.55e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—HMOX1—coronary artery disease	6.48e-07	5.54e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	6.48e-07	5.54e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	6.48e-07	5.54e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—PIK3CA—coronary artery disease	6.45e-07	5.51e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MMP9—coronary artery disease	6.44e-07	5.5e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—APOE—coronary artery disease	6.44e-07	5.5e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MMP9—coronary artery disease	6.43e-07	5.49e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	6.43e-07	5.49e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CAT—coronary artery disease	6.4e-07	5.46e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	6.37e-07	5.44e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—APOA1—coronary artery disease	6.37e-07	5.44e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—AKT1—coronary artery disease	6.35e-07	5.43e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	6.31e-07	5.39e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	6.3e-07	5.38e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	6.29e-07	5.37e-06	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	6.26e-07	5.35e-06	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL6—coronary artery disease	6.26e-07	5.35e-06	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL6—coronary artery disease	6.25e-07	5.34e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	6.25e-07	5.34e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	6.25e-07	5.33e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	6.24e-07	5.33e-06	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL6—coronary artery disease	6.21e-07	5.31e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOB—coronary artery disease	6.21e-07	5.3e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	6.2e-07	5.3e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	6.17e-07	5.27e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	6.16e-07	5.26e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	6.15e-07	5.25e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	6.12e-07	5.23e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	6.12e-07	5.22e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	6.1e-07	5.21e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—PIK3CA—coronary artery disease	6.08e-07	5.2e-06	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL6—coronary artery disease	6.08e-07	5.19e-06	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—PIK3CA—coronary artery disease	6.05e-07	5.17e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GSTM1—coronary artery disease	6.04e-07	5.16e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	6.04e-07	5.16e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	6.03e-07	5.15e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—PIK3CA—coronary artery disease	6e-07	5.13e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	6e-07	5.12e-06	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL6—coronary artery disease	5.98e-07	5.11e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—ALB—coronary artery disease	5.95e-07	5.09e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	5.95e-07	5.08e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—LPL—coronary artery disease	5.93e-07	5.06e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—VEGFA—coronary artery disease	5.88e-07	5.02e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	5.86e-07	5.01e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	5.83e-07	4.98e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	5.79e-07	4.94e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GPX1—coronary artery disease	5.78e-07	4.94e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	5.77e-07	4.93e-06	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—AKT1—coronary artery disease	5.77e-07	4.93e-06	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—AKT1—coronary artery disease	5.77e-07	4.93e-06	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—AKT1—coronary artery disease	5.73e-07	4.89e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL6—coronary artery disease	5.71e-07	4.88e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—NOS3—coronary artery disease	5.69e-07	4.86e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	5.69e-07	4.86e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	5.67e-07	4.84e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CD36—coronary artery disease	5.63e-07	4.81e-06	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—AKT1—coronary artery disease	5.61e-07	4.79e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PPARG—coronary artery disease	5.61e-07	4.79e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	5.56e-07	4.75e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—POMC—coronary artery disease	5.53e-07	4.73e-06	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—AKT1—coronary artery disease	5.52e-07	4.72e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	5.47e-07	4.67e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	5.42e-07	4.63e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TGFB1—coronary artery disease	5.4e-07	4.61e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL6—coronary artery disease	5.39e-07	4.6e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	5.35e-07	4.57e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—MTHFR—coronary artery disease	5.34e-07	4.56e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL6—coronary artery disease	5.32e-07	4.54e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	5.31e-07	4.54e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	5.3e-07	4.53e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MAPK1—coronary artery disease	5.29e-07	4.52e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—AKT1—coronary artery disease	5.27e-07	4.5e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	5.26e-07	4.5e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	5.23e-07	4.47e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	5.21e-07	4.45e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PTGS2—coronary artery disease	5.21e-07	4.45e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	5.2e-07	4.45e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	5.2e-07	4.44e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	5.2e-07	4.44e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	5.1e-07	4.36e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—AGT—coronary artery disease	5.07e-07	4.33e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	5.06e-07	4.32e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ALB—coronary artery disease	5.04e-07	4.31e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—AKT1—coronary artery disease	4.97e-07	4.25e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOE—coronary artery disease	4.97e-07	4.25e-06	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—AKT1—coronary artery disease	4.95e-07	4.22e-06	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—PIK3CA—coronary artery disease	4.92e-07	4.2e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOA1—coronary artery disease	4.91e-07	4.2e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—AKT1—coronary artery disease	4.9e-07	4.19e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL6—coronary artery disease	4.84e-07	4.14e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	4.83e-07	4.13e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—NOS3—coronary artery disease	4.82e-07	4.12e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL6—coronary artery disease	4.8e-07	4.1e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	4.74e-07	4.05e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL6—coronary artery disease	4.74e-07	4.05e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL6—coronary artery disease	4.63e-07	3.96e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL6—coronary artery disease	4.61e-07	3.94e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	4.59e-07	3.92e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	4.52e-07	3.86e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	4.51e-07	3.85e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL6—coronary artery disease	4.48e-07	3.83e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—AKT1—coronary artery disease	4.47e-07	3.82e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	4.43e-07	3.78e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	4.43e-07	3.78e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PTGS2—coronary artery disease	4.41e-07	3.77e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—AKT1—coronary artery disease	4.37e-07	3.73e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PPARG—coronary artery disease	4.33e-07	3.7e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—AKT1—coronary artery disease	4.27e-07	3.65e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—POMC—coronary artery disease	4.27e-07	3.65e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—AKT1—coronary artery disease	4.25e-07	3.63e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	4.14e-07	3.53e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	4.11e-07	3.51e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL6—coronary artery disease	4.07e-07	3.47e-06	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—AKT1—coronary artery disease	4.02e-07	3.43e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL6—coronary artery disease	4e-07	3.42e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL6—coronary artery disease	3.99e-07	3.41e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL6—coronary artery disease	3.92e-07	3.35e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ALB—coronary artery disease	3.89e-07	3.32e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—AKT1—coronary artery disease	3.75e-07	3.21e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—NOS3—coronary artery disease	3.72e-07	3.18e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—AKT1—coronary artery disease	3.69e-07	3.15e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—AKT1—coronary artery disease	3.68e-07	3.15e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL6—coronary artery disease	3.64e-07	3.11e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	3.62e-07	3.09e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PTGS2—coronary artery disease	3.41e-07	2.91e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	3.36e-07	2.87e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	3.2e-07	2.74e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	2.71e-07	2.32e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—AKT1—coronary artery disease	2.62e-07	2.24e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—AKT1—coronary artery disease	2.22e-07	1.89e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.09e-07	1.79e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—AKT1—coronary artery disease	1.71e-07	1.46e-06	CbGpPWpGaD
